Claim 1: Composition comprising as Active Ingredients: (a) extract of Rice Fermented with Monascus purpureus； (b) at least one omega-3 Fatty Acid； (c) l-carnitine or a Salt thereof； and one or more of the following Active Ingredients: (d) at least one policosanol, or a extrac To natural containing policosanols； (e) or a natural extract that contains Resveratrol resveratrol (F；Coenzyme Q10； and (g)) at least one Vitamin.Claim 3: the composition according to claim 1, characterized in that it comprises as active ingredients (a) extract of Monascus purpureus on Rice Fermented with a dose of 1 mg dose are preferred to 3000 mg 10 mg to 2000 mg, 200 mg dose is Preferred； (b) At least one omega-3 Fatty Acid in a dose of 1 mg to 2000 mg, Preferred doses are 10 mg to 1000 mg,The preferred dose is 600 mg； (c) L - carnitine or its salt in a dose of 1 mg dose are preferred to 3000 mg 10 mg to 1000 mg, the dose of 100 mg is more Preferred as inner salt； (d) at least one policosanol, or a natural extract that contains policosanol in a dose of 0.1 mg to 1000 mg dose, Preferred from 1 mg to 100 mg, the dose is 10 mg more Preferred； (e) a natural extract containing resveratrol and resveratrol in a dose of 0.1 mg to 1000 mg, Preferred dose is 1 mg to 100 mg, the dose is 10 mg (Preferred； (f) coenzyme Q10 in a dose of 0.1 mg to 1000 mg, Preferred dose is 1 mg to 100 mg, the preferred dose is 10 mg Vitamin B6； (g) in a dose of 0.03 mg to 300 mg dose Preferred are 0.3 mg to 30 mg, 3 mg dose is Preferred； (H) and Vitamin B12 mcg 250 mcg dose of 0.025, 0.25 mcg dose are preferred 2 5 mcg, the preferred dose is 2.5 mcg.Claim 6: Composition according to claim 1, to be used for the Prevention or treatment of altered Metabolism of Lipids and its Complications, where such complications are selected from the group consisting of cardiovascular diseases, ateroscler u00f3t Icas and / or tromboemb u00e1licas.Claim 7: the composition according to claim 1, for use as a Medicine. Claim 8: the composit
